Open Access

Efficacy of alogliptin combined with motor imagery under hyperbaric oxygen in diabetic nephropathy with silent cerebral infarction

  • Authors:
    • Danyan Chen
    • Xiaolong Huang
    • Hua Gan
    • Xiaogang Du
    • Song Lu
    • Rongxi Huang
    • Ke Liu
    • Binghan Zhang
  • View Affiliations

  • Published online on: September 14, 2017     https://doi.org/10.3892/br.2017.983
  • Pages: 407-415
  • Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In the present study, we evaluated the curative effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor alogliptin combined with motor imagery under hyperbaric oxygen in diabetic nephropathy (DN) with silent cerebral infarction (SCI). Two-hundred newly diagnosed DN patients with and without SCI were included. The SCI patients were divided into two treatment groups: Alogliptin (A group, n=50) and alogliptin combined with motor imagery under hyperbaric oxygen (B group, n=50). The degrees of neurocognitive dysfunction were evaluated at baseline and after 6 months of treatment. Thromboelastograms (TEGs) mapping were conducted. Serum glycoprotein VI (GPVI) mRNA expression and urine 11-DH-TXB2 levels were determined. Compared to group A patients, the severity of neurofunctional defects, GPVI mRNA expression and 11-DH-TXB2 levels were significantly lower in group B (P<0.05), while comprehensive, MoCA scores were higher in group B. The MoCA subscores of visuospatial/executive function, attention and concentration were significantly higher compared to group A (P<0.05). The sub-scores of computation, abstract thinking, language competence, memory and orientation were also higher in group B but the differences were not significant (P>0.05). TEG indexes were improved in both groups after treatment as manifested by increased R and K values, but there was significant improvement in group B. Intra-group comparisons revealed a time‑dependent effect of treatment. In conclusion, the treatment of alogliptin combined with motor imagery under hyperbaric oxygen can better promote thrombolysis absorption, restore brain damage and improve neurocognitive function in DN with silent cerebral infarction.
View Figures
View References

Related Articles

Journal Cover

November-2017
Volume 7 Issue 5

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen D, Huang X, Gan H, Du X, Lu S, Huang R, Liu K and Zhang B: Efficacy of alogliptin combined with motor imagery under hyperbaric oxygen in diabetic nephropathy with silent cerebral infarction. Biomed Rep 7: 407-415, 2017
APA
Chen, D., Huang, X., Gan, H., Du, X., Lu, S., Huang, R. ... Zhang, B. (2017). Efficacy of alogliptin combined with motor imagery under hyperbaric oxygen in diabetic nephropathy with silent cerebral infarction. Biomedical Reports, 7, 407-415. https://doi.org/10.3892/br.2017.983
MLA
Chen, D., Huang, X., Gan, H., Du, X., Lu, S., Huang, R., Liu, K., Zhang, B."Efficacy of alogliptin combined with motor imagery under hyperbaric oxygen in diabetic nephropathy with silent cerebral infarction". Biomedical Reports 7.5 (2017): 407-415.
Chicago
Chen, D., Huang, X., Gan, H., Du, X., Lu, S., Huang, R., Liu, K., Zhang, B."Efficacy of alogliptin combined with motor imagery under hyperbaric oxygen in diabetic nephropathy with silent cerebral infarction". Biomedical Reports 7, no. 5 (2017): 407-415. https://doi.org/10.3892/br.2017.983